Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.45 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | TERT | O14746 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 3/20 | 0.44 |
| ▸ | PPARD | Q03181 | 3/20 | 0.44 |
| ▸ | PPARA | Q07869 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | BLM | P54132 | 2/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | FABP4 | P15090 | 2/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | GMNN | O75496 | 1/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5078165 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL2018468 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL8744318 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL8744392 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL8744391 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL8544644 | 1.00 | EPHX1 (0.45) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL127722 | 0.98 | EPHX1 (0.42) | EPHX1EP300TSHRTERTPTPN1 | |
| SCHEMBL127597 | 0.91 | — | — | |
| SCHEMBL128030 | 0.81 | — | — | |
| SCHEMBL23924683 | 0.81 | FAAH (0.51) | EP300TSHRTERTPTPN1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104232269-A | Molybdenum-containing internal combustion engine oil and preparation method and application thereof | BEIJING HYUNDAI LUBE PRODUCE CO LTD | 2014-12-24 | — | — | CN | disclosed |
| EP-2243805-B1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION CONTAINING THE ANTHRAPYRIDONE COMPOUND, AND COLORED BODY | NIPPON KAYAKU KK (JP) | 2014-11-26 | — | — | EP | disclosed |
| CN-101679901-B | Lubricating oil composition for internal combustion engine | IDEMITSU KOSAN CO | 2013-06-12 | — | — | CN | disclosed |
| CN-101511983-B | Lubricating oil composition for internal combustion engine | IDEMITSU KOSAN CO | 2012-07-11 | — | — | CN | disclosed |
| US-7985287-B2 | Anthrapyridone compound or a salt thereof, magenta ink composition containing the anthrapyridone compound and colored product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-07-26 | — | — | US | disclosed |
| US-20100291360-A1 | Anthrapyridone Compound Or A Salt Thereof, Magenta Ink Composition Containing The Anthrapyridone Compound and Colored Product | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2010-11-18 | — | — | US | disclosed |
| EP-2243805-A1 | ANTHRAPYRIDONE COMPOUND OR SALT THEREOF, MAGENTA INK COMPOSITION CONTAINING THE ANTHRAPYRIDONE COMPOUND, AND COLORED BODY | Nippon Kayaku Kabushiki Kaisha (JP) | 2010-10-27 | — | — | EP | disclosed |
| CN-101679901-A | Lubricating oil composition for internal combustion engine | IDEMITSU KOSAN CO | 2010-03-24 | — | — | CN | disclosed |
| CN-101511983-A | Lubricating oil composition for internal combustion engine | IDEMITSU KOSAN CO (JP) | 2009-08-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100291360-A1 | Anthrapyridone Compound Or A Salt Thereof, Magenta Ink Composition Containing The Anthrapyridone Compound and Colored Product | MLLT3, MLLT1, H1-3 | EPHX1 3796/4885EP300 438/4885TSHR 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.